A Multi-Targeted Antisense Oligonucleotide-Based Therapy Directed at Phosphodiesterases 4 and 7 for COPD

QR Code

A Multi-Targeted Antisense Oligonucleotide-Based Therapy Directed at Phosphodiesterases 4 and 7 for COPD

None

Saved in:

Bibliographic Details
Main Authors:	Seguin, Rosanne, Ferrari, Nicolay
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/30180
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Antisense oligonucleotides targeting IRF4 alleviate psoriasis
by: Yanxia Yu, et al.
Published: (2025-07-01)

Pharmacokinetics of antisense oligonucleotide drugs
by: M. R. Khaitov, et al.
Published: (2013-04-01)

Antisense oligonucleotides for the arterial hypertension mechanisms study and therapy
by: L. O. Klimov, et al.
Published: (2018-04-01)

Programmable Single-Stranded Circular Antisense Oligonucleotides for Multitarget Gene Therapy
by: Yufan Pan, et al.
Published: (2025-07-01)

Antisense oligonucleotides targeting the SARS-CoV-2 nucleocapsid gene decrease viral titers in hamsters
by: Christopher Fitzpatrick, et al.
Published: (2025-09-01)

ANTISENSE OLIGONUCLEOTIDES AND THERAPEUTICAL MONOCLONAL ANTIBODIES AS A BASEMENT FOR NOVEL BIOLOGICAL LIPIDLOWERING DRUGS
by: O. I. Afanasieva, et al.
Published: (2018-09-01)

Antisense oligonucleotide therapy for patients with Friedreich’s ataxia carrying the c.165+5G>C splicing mutation
by: Pouiré Yameogo, et al.
Published: (2025-09-01)

Delivering LINE1 antisense oligonucleotides via endothelial targeting extracellular vesicles to ameliorate myocardial infarction-induced cardiac senescence
by: Enze Fu, et al.
Published: (2025-11-01)

A splice‐switching antisense oligonucleotide targeting APP reduces accumulation of α‐synuclein in a mouse model of Parkinson's disease
by: Rijwan U. Ahammad, et al.
Published: (2025-04-01)

Analysis of Use of Antisense Oligonucleotides for Prevention and Treatment of Hazardous and Extremely Hazardous Viral Infectious Diseases
by: A. A. Petrov, et al.
Published: (2020-05-01)

SARM1 activation induces reversible mitochondrial dysfunction and can be prevented in human neurons by antisense oligonucleotides
by: Andrea Loreto, et al.
Published: (2025-09-01)

Human Telomerase Reverse Transcriptase Gene Antisense Oligonucleotide Increases the Sensitivity of Pancreatic Cancer Cells to Gemcitabine In Vitro
by: Liu, Yong-ping, et al.
Published: (2012)

A dual fluorescence-based reporter assay for real-time determination of siRNA- and antisense oligonucleotide-mediated knockdown
by: Felix Heß, et al.
Published: (2025-09-01)

Effect of liposome binding antisense oligonucleotide BP1003 on albumin-bound paclitaxel sensitivity in pancreatic cancer cells by inhibiting STAT3
by: FU Hua, ZHOU Guochao, CAI Rongmin, SONG Xin, YANG Dinghua
Published: (2025-05-01)

Targeting Phosphodiesterase 4 in Gastrointestinal and Liver Diseases: From Isoform-Specific Mechanisms to Precision Therapeutics
by: Can Chen, et al.
Published: (2025-05-01)

Site-Directed Mutagenesis Using Oligonucleotide-Based Recombineering
by: Gerlach, Roman G., et al.
Published: (2013)

Use of phosphodiesterase 4 inhibitor in patients with psoriatic arthritis
by: V. I. Mazurov, et al.
Published: (2017-04-01)

PERSPECTIVES OF ANTISENSE GENE THERAPY IN ORGAN TRANSPLANTATION
by: O. N. Reznik, et al.
Published: (2013-03-01)

Phosphodiesterase 10A as a Therapeutic Target in Neuropsychopharmacology: A Review
by: A. R. Dorotenko, et al.
Published: (2025-05-01)

Oligonucleotide Applications for the Therapy and Diagnosis of Human Papillomavirus Infection
by: Benítez-Hess, María L., et al.
Published: (2012)

The place of a phosphodiesterase 4 inhibitor in the treatment strategy for psoriatic arthritis
by: V. I. Mazurov, et al.
Published: (2018-04-01)

Endogenous Ribonucleases: Therapeutic Targeting of the Transcriptome Through Oligonucleotide-Triggered RNA Inactivation
by: Daria A. Chiglintseva, et al.
Published: (2025-07-01)

Effect of phosphodiesterase inhibitors on platelet function
by: Ravi Hochuli, et al.
Published: (2025-09-01)

Interaction of Oligonucleotides with Gold Nanoparticles: Factors Beyond Electrostatic and Van‐Der Waals Forces
by: Shaila Thakur, et al.
Published: (2025-07-01)

LIPID METABOLISM CORRECTION BY ANTISENSE TECHNOLOGY
by: O. I. Afanasieva, et al.
Published: (2015-09-01)

Changes induced in mouse lipid metabolism by simultaneous impact of antisense oligonucleotide derivatives to <i>apoB</i>, <i>PCSK9</i>, and <i>apoCIII</i> mRNAs
by: S. I. Oshevski, et al.
Published: (2020-01-01)

miRNA-targeting oligonucleotide constructs with various mechanisms of action as effective inhibitors of carcinogenesis
by: S. K. Miroshnichenko, et al.
Published: (2024-07-01)

cAMP/PKA/CREB/GLT1 signaling involved in the antidepressant-like effects of phosphodiesterase 4D inhibitor (GEBR-7b) in rats
by: Liu X, et al.
Published: (2016-01-01)

Alterations in Expression and Function of Phosphodiesterases in Huntington’s Disease
by: Laprairie, Robert, et al.
Published: (2012)

A review of phosphodiesterase type 5 inhibitors
by: N. Schellack, et al.
Published: (2014-05-01)

Developing the Strategy to Use Silk Spheres for Efficient, Targeted Delivery of Oligonucleotide Therapeutics to Cancer Cells
by: Molenda S, et al.
Published: (2025-06-01)

The Phosphodiesterase 4 Inhibitor Roflumilast Protects Microvascular Endothelial Cells from Irradiation-Induced Dysfunctions
by: Nathalie Guitard, et al.
Published: (2025-07-01)

Functionalized oligonucleotides, synthetic catalysts as enzyme mimics
by: Chardet, Crystalle, et al.
Published: (2024-04-01)

Aptamer-mediated delivery of therapeutic oligonucleotides in glioblastoma
by: Giorgia Castellani, et al.
Published: (2025-10-01)

Time course of fluorescent-labelled oligonucleotide accumulation in cells with the use of folate receptor-targeted cationic liposomes
by: E. V. Shmendel, et al.
Published: (2024-07-01)

Luteolin prevents fMLP-induced neutrophils adhesion via suppression of LFA-1 and phosphodiesterase 4 activity
by: Dai-xun JIANG, et al.
Published: (2015-01-01)

Influence of gallic acid on porcine neutrophils phosphodiesterase 4, IL-6, TNF-α and rat arthritis model
by: Dai-xun JIANG, et al.
Published: (2015-04-01)

MANAGEMENT OF ERECTILE DYSFUNCTION IN CARDIOVASCULAR PATIENTS WITH COMORBIDITIES: REVIEW OF THE TRIALS ON CONTINUING THERAPY WITH PHOSPHODIESTERASE-5 MEDICATIONS
by: G. G. Sharvadze, et al.
Published: (2018-06-01)

RESOLUTION OF THE COUNCIL OF EXPERTS ON «THE PLACE OF PHOSPHODIESTERASE-4 INHIBITOR IN THE COMBINATION TREATMENT OF MODERATE TO SEVERE PSORIASIS AND ACTIVE PSORIATIC ARTHRITIS»
Published: (2017-07-01)

Analysis of efficiency of purification of HEX-oligonucleotides obtained by modified deblocking
by: A. G. Mosina, et al.
Published: (2012-08-01)